| HLA B* 5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors SA Migueles, MS Sabbaghian, WL Shupert, MP Bettinotti, FM Marincola, ... Proceedings of the National Academy of Sciences 97 (6), 2709-2714, 2000 | 1296 | 2000 |
| SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ... The Journal of clinical investigation 131 (5), 2021 | 236 | 2021 |
| Heterogeneous expression of melanoma‐associated antigens and HLA‐A2 in metastatic melanoma in vivo JN Cormier, YM Hijazi, A Abati, P Fetsch, M Bettinotti, SM Steinberg, ... International journal of cancer 75 (4), 517-524, 1998 | 201 | 1998 |
| Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide SR McCurdy, YL Kasamon, CG Kanakry, J Bolaños-Meade, HL Tsai, ... Haematologica 102 (2), 391, 2017 | 178 | 2017 |
| Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination KH Lee, MC Panelli, CJ Kim, AI Riker, MP Bettinotti, MM Roden, P Fetsch, ... The Journal of Immunology 161 (8), 4183-4194, 1998 | 165 | 1998 |
| Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes MP Bettinotti, K Hartung, H Deicher, G Messer, E Keller, EH Weiss, ... Immunogenetics 37 (6), 449-454, 1993 | 117 | 1993 |
| Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project VM Pratt, B Zehnbauer, JA Wilson, R Baak, N Babic, M Bettinotti, A Buller, ... The Journal of molecular diagnostics 12 (6), 835-846, 2010 | 111 | 2010 |
| CD177: A member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera DF Stroncek, L Caruccio, M Bettinotti Journal of translational medicine 2, 1-9, 2004 | 105 | 2004 |
| Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an In vitro melanoma model JN Cormier, MC Panelli, JA Hackett, MP Bettinotti, A Mixon, J Wunderlich, ... International journal of cancer 80 (5), 781-790, 1999 | 102 | 1999 |
| CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects SL Slezak, M Bettinotti, S Selleri, S Adams, FM Marincola, DF Stroncek Journal of translational medicine 5, 1-16, 2007 | 98 | 2007 |
| Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis LC Cappelli, MT Dorak, MP Bettinotti, CO Bingham III, AA Shah Rheumatology 58 (3), 476-480, 2019 | 94 | 2019 |
| Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading KM Lally, S Mocellin, GA Ohnmacht, MB Nielsen, M Bettinotti, MC Panelli, ... International journal of cancer 93 (6), 841-847, 2001 | 92 | 2001 |
| Nonradioactive HLA class II typing using polymerase chain reaction and digoxigenin-11-2′-3′-dideoxyuridinetriphosphate-labeled oligonucleotide probes C Nevinny-Stickel, M Bettinotti, A Andreas, M Hinzpeter, K Mühlegger, ... Human immunology 31 (1), 7-13, 1991 | 88 | 1991 |
| Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas K Hanada, DM Perry-Lalley, GA Ohnmacht, MP Bettinotti, JC Yang Cancer research 61 (14), 5511-5516, 2001 | 86 | 2001 |
| A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12 MC Panelli, MP Bettinotti, K Lally, GA Ohnmacht, Y Li, P Robbins, A Riker, ... The Journal of Immunology 164 (8), 4382-4392, 2000 | 84 | 2000 |
| HLA-DRB5* 0101 and-DRB1* 1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype E Prat, U Tomaru, L Sabater, DM Park, R Granger, N Kruse, JM Ohayon, ... Journal of neuroimmunology 167 (1-2), 108-119, 2005 | 78 | 2005 |
| HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities DE Gladstone, MP Bettinotti Hematology 2014, the American Society of Hematology Education Program Book …, 2017 | 73 | 2017 |
| Stringent allele/epitope requirements for MART-1/Melan A immunodominance: implications for peptide-based immunotherapy MP Bettinotti, CJ Kim, KH Lee, M Roden, JN Cormier, M Panelli, ... The Journal of Immunology 161 (2), 877-889, 1998 | 72 | 1998 |
| Grade II acute graft-versus-host disease and higher nucleated cell graft dose improve progression-free survival after HLA-haploidentical transplant with post-transplant … SR McCurdy, CG Kanakry, HL Tsai, YL Kasamon, MM Showel, ... Biology of Blood and Marrow Transplantation 24 (2), 343-352, 2018 | 70 | 2018 |
| HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis C Paul, U Schoenwald, H Truckenbrodt, MP Bettinotti, G Brünnler, ... Immunogenetics 37, 442-448, 1993 | 67 | 1993 |
